| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 138 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 138 |
| 2 | TACROLIMUS | 121 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 116 |
| 4 | TACROLIMUS OINTMENT 0.1% | 116 |
| 5 | CYCLOSPORINE | 113 |
| 6 | METHOTREXATE SODIUM | 101 |
| 7 | METHOTREXATE | 89 |
| 8 | FLUDARABINE PHOSPHATE | 85 |
| 9 | CYCLOPHOSPHAMIDE | 72 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PALIFERMIN | 4 | 0.0103 |
| 1 | THIOTEPA | 32 | 0.0033 |
| 2 | BUSULFAN | 50 | 0.0031 |
| 3 | FLUDARABINE PHOSPHATE | 85 | 0.0021 |
| 4 | ALEMTUZUMAB | 37 | 0.0019 |
| 5 | BELUMOSUDIL | 5 | 0.0015 |
| 6 | SIROLIMUS | 20 | 0.0015 |
| 7 | GRANULOCYTE COLONY STIMULATING FACTOR | 3 | 0.0014 |
| 8 | LETERMOVIR | 4 | 0.0012 |
| 9 | GILTERITINIB | 5 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 167 |
| 1 | Calcineurin Inhibitor Immunosuppressant [EPC] | 113 |
| 2 | Alkylating Drug [EPC] | 112 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 89 |
| 4 | Kinase Inhibitor [EPC] | 65 |
| 5 | Janus Kinase Inhibitor [EPC] | 39 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 37 |
| 7 | Azole Antifungal [EPC] | 25 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 25 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 4 | 0.0103 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 37 | 0.0019 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 4 | 0.0012 |
| 3 | Antimetabolite Immunosuppressant [EPC] | 20 | 0.0009 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 113 | 0.0009 |
| 5 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 6 | Antimalarial [EPC] | 6 | 0.0006 |
| 7 | Antiprotozoal [EPC] | 6 | 0.0006 |
| 8 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 9 | Alkylating Drug [EPC] | 112 | 0.0005 |